CYP cynata therapeutics limited

Ann: Investor Presentation, page-593

  1. 4,863 Posts.
    lightbulb Created with Sketch. 344
    I will set you a challenge then to declare.

    "Everything I am researching says beware of tumorous cell splitting mutations?"

    That is my statement so I now want you to declare that there is..... no possibility of tumorous mutations with iPSC therapy?

    Declare it with proof of actual therapy in humans and we can move on.

    I get it that we all see stem cells as the golden ticket.

    Some are just a bit more greedy and the FDA need to go with nature before artificial when something is new to approval.
    Last edited by gavint66: 25/06/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $1.021K 6.379K

Buyers (Bids)

No. Vol. Price($)
4 77738 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 3400 1
View Market Depth
Last trade - 09.59am 24/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.